Clinical Blogs

FDA Approves an Absurd Labeling Change for Duexis

Brian Williams, PharmD
Clinical Research Fellow

Why take two pills when you only have to take one? That was the philosophy of Horizon Pharma in developing Duexis®, a medication that combines two common and inexpensive medications  — ibuprofen, an NSAID, and famotidine, a stomach protectant — into one tablet. The least effective medication is one that the patient doesn’t take, so …

A Softer View of Drug Addiction

by Michael Nguyen, PharmD, CPh
Director of Clinical Pharmacy

Michael Nguyen

In a first report of its kind, the Office of the Surgeon General is providing a framework for addressing America’s crippling alcohol and drug addiction problem. The 428-page report, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health, contains a chapter on neurobiology, which compares alcohol and substance addiction to other …

How Will the 21st Century Cures Act Impact Workers’ Comp?

by Devin Motley
Regulatory Counsel

On December 13, 2016, President Obama signed H.R.34, known as the 21st Century Cures Act, into law. Advertised as a victory for bi-partisan cooperation in Congress, the legislation aims to tackle critical health issues facing American society including combating the opioid epidemic, funding cancer research, addressing mental health care, and modifying what approval is required …

Proposed Legislation in Pennsylvania: Senate Bill 1349

by Devin Motley
Regulatory Counsel

Pennsylvania Senate Bill 1349 introduced 10/12/16 would make Pennsylvania the latest state to limit opioid prescriptions. There are three key points to the legislation: Seven-Day Limitation As a general rule, medical professionals “may not prescribe to an individual more than a seven-day supply of a controlled substance containing an opioid.” If a prescriber in their …